Results 91 to 100 of about 3,957,184 (313)

Carpal tunnel surgery: patient preferences and predictors for satisfaction

, 2012
Grant D Shifflett, Christopher J Dy, Aaron DaluiskiDepartment of Orthopaedic Surgery, Division of Hand and Upper Extremity Surgery, Hospital for Special Surgery, New York, NY, USAAbstract: Carpal tunnel syndrome is a debilitating disease of the upper ...
Daluiski A, Dy CJ, Shifflett GD
core  

Patient experiences of, and preferences for, surgical wound care education

, 2022
The aim of this study was to describe patients' experiences of, and preferences for, surgical wound care discharge education and how these experiences predicted their ability to self-manage their surgical wounds.
Kang, Evelyn, O'Connor, Tom, Webber, Louise, Perger, Debra, Evelyn Kang, Latimer, Sharon, Walker, Rachel M, Anne M. Eskes, Sharon Latimer, Georgia Tobiano, Gillespie, Brigid M, Carlini, Joan, Eskes, Anne M, Debra Perger, Brigid M. Gillespie, Tom O'Connor, Louise Webber, Tobiano, Georgia, Joan Carlini, Rachel M. Walker, Chaboyer, Wendy, Wendy Chaboyer   +21 more
core   +1 more source

Preferences of overweight and obese patients for weight loss programs: a discrete-choice experiment

International Journal of Integrated Care, 2013
Introduction: Obesity is associated with increased risk of morbidity and mortality and also appears to have an adverse effect on health-related quality of life.
Axel Mühlbacher, Susanne Bethge
doaj  

Myeloma Patient Value Mapping: A Discrete Choice Experiment on Myeloma Treatment Preferences in the UK

Patient Preference and Adherence, 2020
Simon Fifer,1 Jayne Galinsky,2 Sarah Richard3 1Community and Patient Preference Research (CaPPRe), Sydney, NSW, Australia; 2Myeloma UK, Edinburgh, Scotland; 3PRMA, Edinburgh, ScotlandCorrespondence: Simon FiferCommunity and Patient Preference Research ...
Fifer S, Galinsky J, Richard S
doaj  

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

Molecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka, Wioleta Cieślik, Wojciech Płaziński, Katarzyna Stępnik, Anna Boguszewska‐Czubara, Elżbieta Kot, Robert Musioł, Mateusz Jasica, Anna Mrozek‐Wilczkiewicz, Katarzyna Malarz   +9 more
wiley   +1 more source

A photo-elicitation study of homeless and marginally housed Veterans’ experiences with patient-centered care [PDF]

, 2018
As part of a qualitatively-driven mixed-methods study, this analysis aimed to describe Veterans Affairs (VA) Homeless Patient Aligned Care Team patients’ experiences with patient-centered care.
Rodriguez, Keri L, Kristina L. Hruska, James Conley, Sestito, Samuel F., Keri L Rodriguez, Mitchell, Michael A, Gordon, Adam J., Michael A Mitchell, Samuel Sestito, Michael Mitchell, Keri Rodriguez, Samuel F. Sestito, Kristina Hruska, Adam Gordon, Conley, James W, Hruska, Kristina L., James W Conley, Adam J. Gordon   +17 more
core   +1 more source

Patient Attitudes to Routine Cognitive Testing in Multiple Sclerosis

Patient Preference and Adherence, 2020
Gitte Lee Mortensen,1 Ásta Theódórsdóttir,2 Tobias Sejbæk,3– 5 Zsolt Illes2,6 1AnthroConsult, Århus C 8000, Denmark; 2Department of Neurology, Odense University Hospital, Odense, Denmark; 3Department of ...
Mortensen GL, Theódórsdóttir Á, Sejbæk T, Illes Z   +3 more
doaj  

Patient Preferences Regarding Device Reuse and Potential of Devices for Reuse - A Study in a Veteran Population

Indian Pacing and Electrophysiology Journal, 2013
Background: Many cardiac patients need and undergo device implants. Veterans’ preferences regarding post-mortem handling of devices are not known. Cardiac patients in low- and middle-income countries who need but cannot afford devices rely on donations ...
Indiresha R. Iyer
doaj   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

Molecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller, Janina Müller, Efstathios‐Iason Vlachavas, Lukas Beumers, Lena Fleischhacker, Sara Burmester, Angelika Wörner, Sabine Karolus, Dominic Helm, Cindy Körner, Stefan Wiemann   +10 more
wiley   +1 more source

Communication preferences in patients with fibromyalgia syndrome: descriptive results and patient characteristics as predictors

, 2014
Antje Ullrich, Johannes Hauer, Erik Farin Medical Center, University of Freiburg, Institute for Quality Management and Social Medicine, Freiburg, Germany Background: Communication with patients with fibromyalgia syndrome (FMS) is often considered ...
Farin E, Hauer J, Ullrich A
core